| Sep 25 2019 |
EUON Study Finds EU Regulatory Framework Ready for Next Generation Nanomaterials |
Bergeson & Campbell, P.C. |
| Sep 25 2019 |
FDA Guidance Clarifies HDE Program Review |
Epstein Becker & Green, P.C. |
| Sep 24 2019 |
DOJ Reaches $21.36 Million Agreement with Compounding Pharmacy, Two of its Executives, and Managing Private Equity Firm to Resolve FCA Allegations |
Robinson & Cole LLP |
| Sep 24 2019 |
StarKist on the Hook for $100M Fine for Tuna Price-Fixing |
Bilzin Sumberg |
| Sep 24 2019 |
Latest Version of TSCA Inventory Includes Unique Identifier Information |
Bergeson & Campbell, P.C. |
| Sep 24 2019 |
Congress Continues to Seek Regulatory Clarity on CBD from FDA |
Keller and Heckman LLP |
| Sep 24 2019 |
NNI Begins Registration for October 8 Webinar on Evaluating Worker and Consumer Exposure to Engineered Nanomaterials |
Bergeson & Campbell, P.C. |
| Sep 23 2019 |
FDA Announces Cooperative Agreement to Implement Produce Safety Rule |
Keller and Heckman LLP |
| Sep 23 2019 |
House Vote on Cannabis Industry-Related SAFE Banking Act Scheduled for September 2019 |
Dinsmore & Shohl LLP |
| Sep 20 2019 |
CBD Food And Drink Products In The EU: The Newest Hot Commodity Or A Regulatory Headache? |
Keller and Heckman LLP |
| Sep 20 2019 |
EPA Includes Unique Identifier Information on Updated TSCA Inventory |
Bergeson & Campbell, P.C. |
| Sep 20 2019 |
Post-BMS, Courts Grapple with the Nexus Between Stream of Commerce Activities and the Plaintiff’s Claim Required for Specific Jurisdiction over Manufacturers in Product Liability Cases |
Faegre Drinker |
| Sep 20 2019 |
Compounding Pharmacy and Private Equity Firm Owner Agree to $21 Million Settlement to Resolve FCA Allegations |
Mintz |
| Sep 20 2019 |
BRAG Biobased Products Blog: September 20, 2019 |
Bergeson & Campbell, P.C. |
| Sep 20 2019 |
First Valsartan, Now Zantac: Cancer Causing Impurities in Foreign-Made Drugs |
Stark & Stark |
| Sep 20 2019 |
The Overlap of Drug Pricing Proposals |
McDermott Will & Schulte LLP |
| Sep 20 2019 |
Milwaukee Warns Residents to “Quit Vaping Immediately” |
Stark & Stark |
| Sep 20 2019 |
USDA Publishes Final Rule to “Modernize” Pork Inspection |
Keller and Heckman LLP |
| Sep 19 2019 |
ECHA Executive Director Authors First EUON Nanopinion Post |
Bergeson & Campbell, P.C. |
| Sep 19 2019 |
Denmark to Ban Fluorinated Compounds in Paper and Paperboard Food Packaging Materials |
Keller and Heckman LLP |
| Sep 19 2019 |
China Amends DMF System on Drug Packaging |
Keller and Heckman LLP |
| Sep 19 2019 |
Marijuana Bank Legislation On Hold But May Take Effect Next Year |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Sep 19 2019 |
Mitch McConnell Introduces Bill Amendment That Would Compel FDA to Issue CBD Enforcement Discretion Policy |
Keller and Heckman LLP |
| Sep 18 2019 |
Consumer Groups and Unions Tell FTC: AbbVie-Allergen Merger Will Deny Access to More Effective and Affordable Drugs |
MoginRubin |
| Sep 18 2019 |
EPA Researches Carbon Nanotubes in 3D Printing Filament |
Bergeson & Campbell, P.C. |
| Sep 18 2019 |
‘Big Tuna’ Antitrust Case Among Latest to Discuss Daubert Test at Class Certification Stage. But What’s Too Rigorous? |
MoginRubin |
| Sep 18 2019 |
Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices |
Robinson & Cole LLP |
| Sep 18 2019 |
FDA Announces Public Meeting to Discuss “A New Era of Smarter Food Safety” |
Keller and Heckman LLP |
| Sep 17 2019 |
Circular Economy and Pollution Reduction Act Stalls in California Legislature |
Keller and Heckman LLP |
| Sep 17 2019 |
FDA Issues Draft Guidance on Reconditioning Fish |
Keller and Heckman LLP |
| Sep 17 2019 |
A Win for Hemp in Court, and What it (Might) Mean for North Carolina |
Ward and Smith, P.A. |
| Sep 17 2019 |
GAO Report Sheds Light on Drug Manufacturers’ Expanded Access Programs |
Mintz |
| Sep 17 2019 |
Opioid Update: MDL Defendants Seek Judge Polster DQ |
Squire Patton Boggs (US) LLP |
| Sep 16 2019 |
$6.5 Million Settlement Reached on Eve of Trial in Class Action Lawsuit Against Chipotle Over the Meaning of “Non-GMO” |
Keller and Heckman LLP |
| Sep 13 2019 |
FDA Adds Eight New Substances to its Inventory of Effective FCS Notifications - September 2019 |
Keller and Heckman LLP |
